The Latest Breaking News from Phibro Animal Health

According to Benzinga Pro, during Q3, Phibro Animal Health (NASDAQ:PAHC) earned $17.69 million, a 1.28% increase from the preceding quarter. Phibro Animal Health also posted a total of $239.60 million in sales, a 2.97% increase since Q2.

The surging demand for animal healthcare products and services has benefited companies operating in this space. Prominent animal healthcare stocks Phibro Animal Health (PAHC) and Zomedica (ZOM) are well-positioned to capitalize on the industry tailwinds. But which of these stocks is a better buy now? Read more to find out.

According to Benzinga Pro, during Q2, Phibro Animal Health (NASDAQ:PAHC) earned $17.46 million, a 167.29% increase from the preceding quarter. Phibro Animal Health also posted a total of $232.70 million in sales, a 8.38% increase since Q1.

Phibro Animal Health (NASDAQ:PAHC) reported its Q2 earnings results on Wednesday, February 9, 2022 at 04:30 PM. Here's what investors need to know about the announcement.